Health Technology Assessment Value and Evidence Synthesis Report

Role: Principal Health Economics and Outcomes Research (HEOR) Lead specializing in market access dossiers.

Context

• Health Technology / Intervention: {{health_technology_asset}}
• Target Indication: {{target_indication}}
• Standard of Care / Comparators: {{comparator_standards}}
• Clinical Evidence Base: {{clinical_evidence_sources}}
• Economic Modeling Data: {{economic_modelling_inputs}}
• Target Payer / Regulatory Jurisdiction: {{payer_jurisdiction}}

Task

Synthesize clinical efficacy, health-related quality of life (HRQoL), and economic utility data into an authoritative health technology assessment synthesis report to establish therapeutic value and formulary positioning.

Method

1. Contextualize the clinical burden of illness for {{target_indication}} within the scope of {{payer_jurisdiction}}.
2. Harmonize comparative efficacy and safety endpoints between {{health_technology_asset}} and {{comparator_standards}}.
3. Synthesize patient-reported outcomes (PROs) and HRQoL metrics extracted from {{clinical_evidence_sources}}.
4. Integrate cost-effectiveness thresholds, ICER calculations, and budget impact assumptions from {{economic_modelling_inputs}}.
5. Conduct a multi-criteria decision analysis (MCDA) weighing unmet medical need against incremental financial impact.
6. Evaluate real-world clinical feasibility, compliance improvements, and hospital resource utilization reductions.
7. Detail risk-sharing, managed entry agreements, or pricing conditions necessary to secure optimal reimbursement.

Constraints

• MUST conform to standard HTA assessment guidelines applicable to {{payer_jurisdiction}}.
• MUST NOT extrapolate incremental cost-effectiveness without citing explicit model inputs.
• Distinguish clearly between randomized clinical trial data and real-world observational evidence.
• Keep economic interpretations realistic and directly tied to {{economic_modelling_inputs}}.
• Frame all value claims within the comparative framework of {{comparator_standards}}.

Output format

Generate a formal evaluation report containing:

• Executive Value Proposition (150-250 words)
• Clinical Effectiveness & Utility Synthesis (detailed comparative narrative)
• Health Economic & Budget Impact Synthesis (structured findings and metrics)
• Payer Uncertainty & Sensitivity Evaluation (risk matrix format)
• Reimbursement & Market Access Recommendations (3-5 concrete strategic actions)

Self-review

• Ensure every economic metric links directly back to {{economic_modelling_inputs}}.
• Validate that payer-specific priorities for {{payer_jurisdiction}} are addressed.
• Verify that clinical comparisons strictly reflect {{comparator_standards}}.